Helix Energy Solutions Group Inc
Change company Symbol lookup
Select an option...
HLX Helix Energy Solutions Group Inc
CTXS Citrix Systems Inc
RAKR Rainmaker Worldwide Inc
CLB Core Laboratories NV
KERN Akerna Corp
T AT&T Inc
YPPN Yappn Corp
RUSHB Rush Enterprises Inc
CMTL Comtech Telecommunications Corp
BMYMP Bristol-Myers Squibb Co

Energy : Energy Equipment & Services | Small Cap Value
Company profile

Helix Energy Solutions Group, Inc. is an international offshore energy services company. The Company provides services to the offshore energy industry, with a focus on well intervention and robotics operations. The Company operates in three segments: Well Intervention, Robotics and Production Facilities. Its Well Intervention segment includes the Company's vessels and equipment used to perform well intervention services primarily in the Gulf of Mexico and North Sea regions. Its Robotics segment includes remotely operated vehicles (ROVs), trenchers and ROVDrills designed to complement offshore construction and well intervention services, and operates chartered ROV support vessels. Its Production Facilities segment includes the Helix Producer I (the HP I), a floating production vessel, the Helix Fast Response System (the HFRS), and its ownership interest in Independence Hub, LLC (Independence Hub).


Last Trade
0.41 (15.71%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates

10:17 am ET July 20, 2020 (MarketWatch)

Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates from Pfizer Inc (http://www.marketwatch.com/story/biontech-pfizer-shares-rally-on-preliminary-data-showing-t-cell-response-from-coronavirus-vaccine-candidate-2020-07-20). (PFE) and BioNTech SE (BNTX) and AstraZeneca PLC (http://www.marketwatch.com/story/astrazenecas-stock-fall-3-as-results-from-early-stage-study-on-coronavirus-vaccine-are-published-2020-07-20)(AZN.LN). Shares of iBio Inc. (IBIO), which is working with Beijing CC-Pharming Ltd. on a plant-based vaccine to treat the coronavirus (http://www.marketwatch.com/story/ibio-shares-soar-another-174-on-hopes-for-china-vaccine-partnership-2020-02-28), soared 43% in morning trading on volume of 45.5 million shares, which is already nearly double the full-day average. Inovio Pharmaceuticals Inc. (INO), which announced last month (http://www.marketwatch.com/story/race-for-a-covid-19-vaccine-has-drug-makers-scaling-up-manufacturing-before-one-is-developed-2020-06-25) that the Department of Defense will pay $71 million to fund the manufacturing of a device used to administer Inovio vaccines, saw its stock drop 7.9%. Among other companies with vaccine candidates, shares of Moderna Inc. (MRNA) sank 12% in active trading after a J.P. Morgan downgrade on valuation concerns (http://www.marketwatch.com/story/jp-morgan-downgrades-moderna-over-valuation-concerns-2020-07-20), Novavax Inc. (NVAX) shed 5%, Vaxart Inc. (VXRT) gained 1.9%. Meanwhile, shares of AstraZeneca fell 2.9%, Pfizer gained 1.8% and BioNTech advanced 4.9%. The S&P 500 was up less than 0.1% in morning trading.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

July 20, 2020 10:17 ET (14:17 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.